论文部分内容阅读
A model for anticancer surveillance was pharmacologically developed to evaluate vitality principle i
【作 者】
：
【出 处】
：
中医杂志（英文版）
【发表日期】
：
2018年6期
其他文献
Mixture prepared with Chinese medicines in terms of releasing exterior cold and clearing interior he
OBJECTIVE:To assess the efficacy and safety in 105 patients with seasonal Influenza in Beijing,the mixture prepared with Chinese medicines follows the treatment
Effect of the herbal medicine Danggui Sini plus Wuzhuyu Shengjiang Tang on erythrocyte deformability
OBJECTIVE:To show whether Danggui Sini plus Wuzhuyu Shengjiang Tang (DSWST) has any transient effect on erythrocyte deformability in normal subjects.METHODS:A t
Evaluation of efficacy and safety of gandouling plus sodium dimercaptosulphonate in treatment of pat
Exploring pathogenesis in subjects with subjective Tinnitus having kidney deficiency pattern in term
OBJECTIVE:To investigate the metabolic pathogenesis in subjects with subjective tinnitus (ST)having kidney deficiency patt (KDP) (ST/KDP) in terms of Traditiona
Effects of Ziyin Jianghuo Ningxin decoction plus dehydroepiandrosterone and femoston in treatment of
OBJECTIVE:To determine the therapeutic effect of Ziyin Jianghuo Ningxin Decoction (ZYJHNXD) plus dehydroepiandrosterone (DHEA) and menopausal hormone therapy (M
Mechanism underlying treatment of diabetic kidney disease using Traditional Chinese Medicine based o
The pathogenic mechanism of diabetic kidney disease (DKD) is complex.The development of DKD cannot be fully explained by a single mechanism.Traditional Chinese
目前,全球约有1.5亿糖尿病患者,截止2003年,我国已经成为糖尿病第2大国,仅次于印度,糖尿病的患病率从1986-1994年增长了近3倍[1].被誉为美国糖尿病教育先驱的Dr.Toslm提出,糖
Involvement of heme oxygenase-1 induction in anti-vascular inflammation effects of Xanthoceras sorbi
OBJECTIVE:To define the effects of Xanthoceras sorbifolia (EXS) on vascular inflammation and the mechanisms in endothelial cells.METHODS:Vascular protective eff
Tanshinone ⅡA improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via n
OBJECTIVE:To investigate whether the Tan Ⅱ A could improve the distribution and anti-tumor efficacy of Pegylated Liposomal Doxorubicin (PLD) via normalizing th